UC Davis Innovation Institute for Food and Health Logo
The statistics say 6% of Americans are currently taking a GLP-1 drug - but that figure could be wildly underestimated. (Image: FoodNavigator EU)

How big is the GLP-1 wave going to get, really?


GLP-1 medications are no longer fringe – they’re mainstream, and they’re reshaping everything from public health to consumer behavior.

According to Kim Fisher, director of programs at the Innovation Institute for Food and Health (IIFH) at UC Davis, the scale of metabolic dysfunction in the US is staggering.

 

More News & Stories

IIFH Involvement